Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CLI

Financiado

Cerrado

The CLIO consortium Optimization of Cerenkov Luminescence Imaging for Image Gui...

The CLIO consortium Optimization of Cerenkov Luminescence Imaging for Image Guided Cancer Surgery Cancer is the second largest cause of death and morbidity in Europe, with more than 3 million new cases diagnosed each year. The most effective treatment strategy for most forms of cancer is early detection followed by surgery. Ho... ver más

30/11/2016

CROMED

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

CROMED KUTATO ES SZOLGALTATO KOZPONTOK KFT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 7 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-11-30 No tenemos la información de la convocatoria

0% 77% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

7 Participantes

CROMED

0.00€ | Lider

OKK-OSSKI

N.D. | Participante

SEMMELWEIS UNIVERSITY

N.D. | Participante

ABX CRO GMBH

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

CerISMA Cerenkov Imaging for Surgical Margin Assessment 2M€ Cerrado

FI2P4TUM Fluorescence intraoperative imaging platform for tumor margi... 163K€ Cerrado

EDOCAL Early Detection Of CAncer using photonic crystal Lasers 2M€ Cerrado

BIO2008-06843-C04-01 AISLAMIENTO NO INVASIVO DE CELULAS TUMORALES CIRCULANTES EN... 121K€ Cerrado

LOUISA 3D Innovative 3 dimensional optoacoustic imaging for safe breas... 71K€ Cerrado

PDC2021-121481-I00 NIR-QUATSOMAS PARA CIRUGIADA GUIADA DE IMAGEN APLICADA A CAN... 150K€ Cerrado

Líder del proyecto

CROMED KUTATO ES SZOLGALTATO KOZPONTOK KFT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancer is the second largest cause of death and morbidity in Europe, with more than 3 million new cases diagnosed each year. The most effective treatment strategy for most forms of cancer is early detection followed by surgery. However, cancers frequently recur following surgery. For example, nearly 1 in 4 breast cancer patients will see their tumour recur after surgery. The consequences of cancer recurrence include repeat operations, delayed adjuvant treatment, increased likelihood of distant recurrence, poorer cosmetic and functional outcomes, emotional distress, and financial cost. The financial costs are staggering. Europe spends €125 billion annually on cancer care, approximately 5% of which is managing post-surgical recurrence. Tumours recur after surgery primarily due to incomplete excision of the tumour or inadequate clearance of surgical margins. Tumours fail to be completely excised because the surgeon only has the visual appearance of the tumor and palpation to differentiate malignant from benign tissue. Consequently, there is an urgent clinical and market need for improved tools to detect cancerous tissue during surgery. Real-time imaging during surgery would enable the surgeon to more accurately resect tumors and thereby reduce the likelihood of post-surgical recurrence. Cerenkov luminescence imaging (CLI) is a ground-breaking imaging modality that can provide real-time molecular imaging during surgery The CLIO consortium will develop a Cerenkov luminescence imaging device and a handheld intraoperative beta particle imaging device for image-guided surgery as well as imaging services for the pharmaceutical and medical device sectors. The imaging services will enable pharmaceutical and medical device clients to improve the efficacy evaluation of pharmaceutical and surgical device products. The consortium contains world-leading expertise in medical device product development, clinical and preclinical imaging, oncologic surgery, and surgical device evaluation.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores